ÍøÆØÃÅ

Technology commercialisation company BTG will invest in Senexis, a biotechnology company that will develop treatments for ageing-related diseases such as Alzheimer's, Parkinson's and Huntington's.

Senexis, based at the University of Manchester Institute of Science and Technology, has raised ?1.4 million from BTG and Catalyst BioMedica Limited to finance its research.